Mutant Calreticulin in the Myeloproliferative Neoplasms. (2020)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/hs9.0000000000000333
PubMed Identifier: 32382708
Publication URI: http://europepmc.org/abstract/MED/32382708
Type: Journal Article/Review
Volume: 4
Parent Publication: HemaSphere
Issue: 1
ISSN: 2572-9241